Table 2.
Descriptive data of neonatal behaviour depending on Hb levels of mothers at the end of pregnancy in the sample of healthy and well-nourished pregnant women and their full-term, normal-weight newborns (n 210), Reus, Spain, 2004–2008
| Third trimester | Delivery | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anaemia (Hb<110 g/l) (n 59) | Normal Hb (Hb=110–130 g/l) (n 138) | Haemoconcentration risk (Hb>130 g/l) (n 13) | Anaemia (Hb<110 g/l) (n 45) | Normal Hb (Hb=110– 130 g/l) (n 140) | Haemoconcentration risk (Hb>130 g/l) (n 25) | |||||||
| Mean | sd | Mean | sd | Mean | sd | Mean | sd | Mean | sd | Mean | sd | |
| NBAS clusters | ||||||||||||
| Habituation | 7·8 | 1·2 | 7·5 | 1·5 | 7·6 | 1·1 | 7·4 | 1·7 | 7·7 | 1·2 | 7·3 | 1·6 |
| Orientation | 5·6 | 1·6 | 5·8 | 1·6 | 5·2 | 1·1 | 5·8 | 1·6 | 5·8 | 1·6 | 5·4 | 2·2 |
| Motor | 5·4 | 0·8 | 5·3 | 1·0 | 5·1 | 0·8 | 5·3 | 0·9 | 5·3 | 0·9 | 5·3 | 1·0 |
| State organization | 3·6 | 1·1 | 3·8 | 0·9 | 3·9 | 0·8 | 3·9 | 0·9 | 3·7 | 1·0 | 3·9 | 0·6 |
| State regulation* | 5·8 | 1·4 | 5·8 | 1·5 | 4·6 | 2·0 | 5·9 | 1·4 | 5·8 | 1·5 | 5·1 | 1·7 |
| Autonomic stability | 7·2 | 0·9 | 7·1 | 1·1 | 6·9 | 1·4 | 7·3 | 0·8 | 7·1 | 1·1 | 7·1 | 1·2 |
| NBAS supplementary items | ||||||||||||
| Alertness | 5·2 | 2·3 | 5·4 | 2·2 | 3·9 | 2·9 | 5·4 | 2·3 | 5·3 | 2·3 | 4·6 | 2·6 |
| Effort to keep attention | 5·8 | 2·1 | 5·7 | 1·8 | 4·5 | 1·8 | 6·0 | 1·8 | 5·7 | 1·9 | 4·9 | 2·0 |
| Examiner facilitation | 5·4 | 2·2 | 5·5 | 2·1 | 4·5 | 2·7 | 5·3 | 2·1 | 5·5 | 2·1 | 5·0 | 2·5 |
| General irritability | 5·6 | 2·5 | 5·7 | 2·2 | 4·3 | 2·7 | 5·8 | 2·3 | 5·7 | 2·3 | 4·6 | 2·3 |
| Robustness endurance | 5·8 | 2·4 | 5·6 | 2·3 | 4·3 | 2·6 | 5·6 | 2·6 | 5·7 | 2·2 | 4·8 | 2·5 |
| State regulation | 6·1 | 2·5 | 6·2 | 2·1 | 5·1 | 2·8 | 6·2 | 2·3 | 6·2 | 2·2 | 5·8 | 2·4 |
| Examiner’s emotional response | 6·1 | 2·3 | 6·1 | 2·1 | 5·1 | 2·4 | 6·1 | 2·1 | 6·0 | 2·2 | 5·7 | 2·3 |
NBAS, Neonatal Behavioral Assessment Scale.
*
Significant P values from Bonferroni post hoc analysis: normal Hb group v. haemoconcentration risk group (P=0·020).